ALIPEM

Inj.  ALIPEMTM – 125 Meropenem 125 mg  VAIL+W.F.I.
Inj. ALIPEMTM – 250 Meropenem 250 mg  VAIL+W.F.I.
Inj.  ALIPEMTM – 500 Meropenem 500 mg  VAIL+W.F.I.
Inj. ALIPEMTM – 1000 Meropenem 1000 mg  VAIL+W.F.I.
Inj. ALIPEMTM  – S Meropenem 1000 mg + Sulbactam Sodium 500 mg.  VAIL+W.F.I.

 

Category: Tag:

The ALIPEM™ range represents a powerful line of broad-spectrum injectable antibiotics containing Meropenem, a carbapenem-class β-lactam antibiotic, designed for severe bacterial infections.
These formulations deliver rapid and reliable bactericidal action against a wide range of Gram-positive, Gram-negative, and anaerobic organisms, including multi-drug-resistant strains.

ALIPEM™-S, the combination of Meropenem with Sulbactam Sodium, provides additional protection against β-lactamase–producing bacteria, making it an advanced choice for complex, hospital-acquired infections.

Product Range: ALIPEM™ Injections

Composition & Strengths:

  • ALIPEM™ 125 – Meropenem 125 mg (Vial + W.F.I.)

  • ALIPEM™ 250 – Meropenem 250 mg (Vial + W.F.I.)

  • ALIPEM™ 500 – Meropenem 500 mg (Vial + W.F.I.)

  • ALIPEM™ 1000 – Meropenem 1000 mg (Vial + W.F.I.)

  • ALIPEM™-S – Meropenem 1000 mg + Sulbactam Sodium 500 mg (Vial + W.F.I.)

Category: Broad-Spectrum Antibiotic | β-Lactam Carbapenem Class
Packaging: Sterile Vial with W.F.I. (Water for Injection)

Mechanism of Action

  • Meropenem: Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.

  • Sulbactam (in ALIPEM™-S): A β-lactamase inhibitor that protects Meropenem from enzymatic degradation, broadening its antibacterial spectrum.

Indications / Therapeutic Uses

ALIPEM™ formulations are indicated for the treatment of:

  • Severe respiratory tract infections (pneumonia, bronchitis)

  • Intra-abdominal infections and peritonitis

  • Skin and soft tissue infections

  • Urinary tract infections (UTIs) including complicated cases

  • Bacterial meningitis

  • Septicemia and bloodstream infections

  • Gynecological and post-surgical infections

Dosage & Administration

  • Administered intravenously (IV) as per physician’s direction.

  • Dosage varies depending on the infection type and patient condition.

  • Available in multiple strengths (125 mg to 1000 mg) for flexible dosing.

  • Reconstitute each vial with the provided W.F.I. (Water for Injection) before use.

Key Features & Advantages

  • Broad-spectrum coverage against Gram-positive, Gram-negative, and anaerobic bacteria.

  • Rapid bactericidal action with excellent tissue penetration.

  • Stable against most β-lactamases and cephalosporinases.

  • ALIPEM™-S provides enhanced activity against resistant pathogens.

  • Manufactured in sterile, WHO-GMP-certified facilities ensuring highest purity standards.

  • Multiple strengths available for all therapeutic needs.

Precautions

  • Use under medical supervision only.

  • Adjust dosage in patients with renal impairment.

  • Monitor for signs of allergic reactions or superinfection.

  • Not to be mixed with other antibiotics in the same syringe/vial.

Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.

For more such product information and similar product category https://www.allengeindia.com/product-category/anti-bacterials/